Mineral Sands

Impact Minerals Limited (ASX:IPT) Annual Report 2017

🕔10/27/2017 4:21:38 PM

Impact Minerals Limited (ASX:IPT) provides the Company's Annual Report 2017.

Read Full Article

Andromeda Metals Ltd (ASX:ADN) Pilbara Gold Project Acquisition, $2 Million Capital Raising and Board Restructure

🕔10/27/2017 11:37:39 AM

Andromeda Metals Ltd (ASX:ADN) announces Pilbara gold project acquisition, $2 million capital raising and board restructure.

Read Full Article

Queensland Bauxite Ltd (ASX:QBL) Anticipated Cashflow from MCL Investment

🕔10/27/2017 9:01:23 AM

The Board of Queensland Bauxite (ASX:QBL) is most excited to announce that via its subsidiary Medical Cannabis Ltd, the initial sample range of hemp products under the name Vitahemp, will be ready for introduction to the Australian market in November 2017. Hemp foods are an extremely nutritious form of food product made from low THC Cannabis.

Read Full Article

Impact Minerals Limited (ASX:IPT) Quarterly Report September 2017

🕔10/27/2017 8:14:21 AM

Impact Minerals Limited (ASX:IPT) provides the Company's Quarterly Report September 2017.

Read Full Article

Cobalt Blue Holdings Limited (ASX:COB) Bulk Metallurgical Testwork - Strong Concentration Results

🕔10/26/2017 11:34:27 AM

Cobalt Blue Holdings Limited (ASX:COB) announces strong concentration results of the bulk metallurgical testwork.

Read Full Article

Cobalt Blue Holdings Limited (ASX:COB) Quarterly Activities and Cash Flow Reports September 2017

🕔10/18/2017 8:26:21 AM

Cobalt Blue Holdings Limited (ASX:COB) provides the Company's Quarterly Activities and Cash Flow Reports for the period ending September 2017.

Read Full Article

Queensland Bauxite Ltd (ASX:QBL) Engagement of Israeli Research Organisation for the Development of Medical Cannabis Products

🕔10/16/2017 10:19:00 AM

The Board of Queensland Bauxite Limited (ASX:QBL) is pleased to announce that further to the significant progress that its subsidiary Medical Cannabis Limited has been making in its business and product development, EndoCRO Ltd an iCAN:Israel-Cannabis company, has been selected as a research and product development arm on a contract basis.

Read Full Article